Nobumichi Tanaka

4.4k total citations
248 papers, 3.0k citations indexed

About

Nobumichi Tanaka is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Nobumichi Tanaka has authored 248 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Pulmonary and Respiratory Medicine, 84 papers in Surgery and 40 papers in Urology. Recurrent topics in Nobumichi Tanaka's work include Prostate Cancer Diagnosis and Treatment (80 papers), Prostate Cancer Treatment and Research (79 papers) and Bladder and Urothelial Cancer Treatments (58 papers). Nobumichi Tanaka is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (80 papers), Prostate Cancer Treatment and Research (79 papers) and Bladder and Urothelial Cancer Treatments (58 papers). Nobumichi Tanaka collaborates with scholars based in Japan, United States and China. Nobumichi Tanaka's co-authors include Kiyohide Fujimoto, Makito Miyake, Satoshi Anai, Yasushi Nakai, Yoshihiko Hirao, Shunta Hori, Kazumasa Torimoto, Noboru Konishi, Yosuke Morizawa and Keiji Shimada and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Nobumichi Tanaka

230 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nobumichi Tanaka Japan	29	1.3k	899	656	649	434	248	3.0k
Takuya Koie Japan	28	1.2k 0.9×	1.2k 1.3×	876 1.3×	507 0.8×	531 1.2×	316	3.2k
Makito Miyake Japan	34	1.1k 0.9×	1.5k 1.7×	1.1k 1.7×	987 1.5×	397 0.9×	305	3.9k
Toshiyuki Kamoto Japan	37	1.6k 1.2×	788 0.9×	1.4k 2.1×	840 1.3×	386 0.9×	262	3.9k
Tetsuya Fujimura Japan	35	1.2k 1.0×	729 0.8×	1.4k 2.2×	686 1.1×	632 1.5×	205	3.8k
Yun‐Sok Ha South Korea	26	1.0k 0.8×	979 1.1×	1.2k 1.8×	451 0.7×	271 0.6×	194	2.8k
Yoshiyuki Matsui Japan	27	733 0.6×	1.0k 1.1×	679 1.0×	444 0.7×	630 1.5×	178	2.6k
Sheldon Bastacky United States	35	868 0.7×	839 0.9×	967 1.5×	303 0.5×	336 0.8×	123	3.7k
Yutaka Horiguchi Japan	26	758 0.6×	785 0.9×	579 0.9×	712 1.1×	221 0.5×	67	2.3k
Seong Il Seo South Korea	32	2.1k 1.6×	1.1k 1.2×	1.0k 1.6×	565 0.9×	767 1.8×	238	3.9k
Naoki Terada Japan	29	1.2k 0.9×	491 0.5×	878 1.3×	267 0.4×	607 1.4×	145	2.6k

Countries citing papers authored by Nobumichi Tanaka

Since Specialization

Citations

This map shows the geographic impact of Nobumichi Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobumichi Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobumichi Tanaka more than expected).

Fields of papers citing papers by Nobumichi Tanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobumichi Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobumichi Tanaka. The network helps show where Nobumichi Tanaka may publish in the future.

Co-authorship network of co-authors of Nobumichi Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Nobumichi Tanaka. A scholar is included among the top collaborators of Nobumichi Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobumichi Tanaka. Nobumichi Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hori, Shunta, Tatsuo Yoneda, Yosuke Morizawa, et al.. (2025). Screening and prognostic roles of renal volumetry and scintigraphy in the assessment of living kidney transplant donors, considering the early recovery of the residual renal function. BMC Nephrology. 26(1). 28–28.

Nakai, Yasushi, Shunta Hori, Daisuke Gotoh, et al.. (2024). Duration of α-1 adrenergic antagonist administration after low-dose-rate brachytherapy for prostate cancer. Japanese Journal of Clinical Oncology. 54(12). 1343–1350. 1 indexed citations

Nakai, Yasushi, Nobumichi Tanaka, Isao Asakawa, et al.. (2024). Efficacy of a hydrogel spacer for improving quality of life in patients with prostate cancer undergoing low‐dose‐rate brachytherapy alone or in combination with intensity‐modulated radiotherapy: An observational study using propensity score matching. The Prostate. 84(12). 1104–1111. 3 indexed citations

Shimizu, Takuto, Makito Miyake, Nobutaka Nishimura, et al.. (2024). Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors. Cancers. 16(4). 841–841. 1 indexed citations

Miyake, Makito, Sayuri Onishi, Tomomi Fujii, et al.. (2024). Photodynamic Therapeutic Effect during 5‐Aminolevulinic Acid‐Mediated Photodynamic Diagnosis‐Assisted Transurethral Resection of Bladder Tumors. Advances in Urology. 2024(1). 7548001–7548001.

Tanaka, Nobumichi, et al.. (2024). Oral 5-aminolevulinic Acid for Patients With Localized Prostate Cancer Undergoing Low-dose-rate Brachytherapy: AMBER Trial. In Vivo. 38(6). 3091–3105. 2 indexed citations

Hori, Shunta, Tatsuo Yoneda, Kuniaki Inoue, et al.. (2023). Chronological Changes in Emotional Status and Vaccine Implementation Rate Among Patients on the Waiting List for Deceased-Donor Kidney Transplantation During the Prolonged COVID-19 Pandemic. Transplantation Proceedings. 55(10). 2354–2361. 1 indexed citations

Hori, Shunta, Kuniaki Inoue, Tatsuo Yoneda, et al.. (2023). Impact of nutrition and inflammation indicators on peritoneal dialysis initiation and management. Clinical and Experimental Nephrology. 28(4). 349–358. 2 indexed citations

Yorozu, Atsunori, Mikio Namiki, Shiro Saito, et al.. (2023). Results of a multicenter, randomized, phase 3 trial of trimodality therapy with I-125 brachytherapy, external beam radiation therapy, and long- versus short-term androgen deprivation therapy for localized high-risk prostate cancer (TRIP/TRIGU0907).. Journal of Clinical Oncology. 41(6_suppl). 305–305. 1 indexed citations

10.

Miyake, Makito, Shunta Hori, Tomomi Fujii, et al.. (2023). Clinical practice of UroVysion® urine test in patients with bladder carcinoma in situ treated with intravesical Bacillus Calmette–Guerin. Japanese Journal of Clinical Oncology. 53(7). 629–632. 1 indexed citations

11.

Nakai, Yasushi, Nobumichi Tanaka, Isao Asakawa, et al.. (2022). Late genitourinary and gastrointestinal toxicity and radiation-induced second primary cancers in patients treated with low-dose-rate brachytherapy. Brachytherapy. 21(5). 626–634. 2 indexed citations

12.

Izumi, Kouji, Takashi Shima, Koji Mita, et al.. (2022). Enzalutamide Versus Abiraterone plus Prednisolone Before Chemotherapy for Castration-resistant Prostate Cancer: A Multicenter Randomized Controlled Trial. European Urology Open Science. 41. 16–23. 7 indexed citations

13.

Miyake, Makito, Takashi Yoshida, Nobutaka Nishimura, et al.. (2022). A prospective, single-arm trial of fluorescent ureteroscopy-assisted thulium-holmium:YAG dual laser ablation for upper urinary tract cancer: Study protocol of the FLUAM trial. Contemporary Clinical Trials Communications. 26. 100902–100902. 6 indexed citations

14.

Kuwada, Masaomi, Shingo Kishi, Rina Fujiwara‐Tani, et al.. (2022). Hypomethylation of CLDN4 Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer. International Journal of Molecular Sciences. 23(12). 6516–6516. 11 indexed citations

15.

Miyake, Makito, Nobutaka Nishimura, Takashi Inoue, et al.. (2021). Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study). Trials. 22(1). 136–136. 5 indexed citations

16.

Hori, Shunta, Nobumichi Tanaka, Tatsuo Yoneda, et al.. (2021). Remnant renal volume can predict prognosis of remnant renal function in kidney transplantation donors: a prospective observational study. BMC Nephrology. 22(1). 367–367. 8 indexed citations

17.

Miyake, Makito, Nobutaka Nishimura, Katsuya Aoki, et al.. (2020). Initial experience of complete laparoscopic radical nephroureterectomy combined with transvesical laparoscopic excision of distal ureter in patients with upper urinary tract cancer. World Journal of Surgical Oncology. 18(1). 104–104. 6 indexed citations

18.

Miyake, Makito, Nobutaka Nishimura, Tomomi Fujii, et al.. (2020). Photodynamic Diagnosis-Assisted En Bloc Transurethral Resection of Bladder Tumor for Nonmuscle Invasive Bladder Cancer: Short-Term Oncologic and Functional Outcomes. Journal of Endourology. 35(3). 319–327. 12 indexed citations

19.

Morizawa, Yosuke, Katsuya Aoki, Shunta Hori, et al.. (2020). Is Endoscopic Transurethral Incision Really Effective for Boys with Refractory Daytime Incontinence?. SHILAP Revista de lepidopterología.

20.

Nishimura, Nobutaka, Shunta Hori, Makito Miyake, et al.. (2020). Living‐donor kidney transplantation for a patient with hypoparathyroidism, deafness, and renal dysplasia syndrome. SHILAP Revista de lepidopterología. 3(6). 244–247. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact